Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

BeOne Medicines (NASDAQ:ONC) gains FDA approval for a new tablet version of Brukinsa, simplifying dosage for patients.

Softgel capsules—the smooth, easy-to-swallow form of many medications and supplements—are increasingly popular for delivering ...

The University of Oxford has received support from European Medicines Agency's (EMA) for its vaccine targeting the deadly ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

The OSOA package creates a common platform that integrates existing databases and offers a 'one-stop shop' for chemical data from EU agencies and the Commission. It enables knowledge sharing from one ...

Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy ...

The European Union (EU) is actively courting biotech for economic growth and has launched several initiatives to attract ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...